QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

Help viewing high resolution images Return to article

Fig. 1. Conditional inactivation of TrkA. (A) Diagram of the replacement vector strategy used to generate the TrkA^neo allele and re-activation of TrkA expression by Cre recombinase. The pGKneobpA cassette flanked by loxP sites was placed into intron 11. (B) Southern blot analysis of tail DNA from three-week-old mice with a 5' external probe shows the switch of the wild-type (WT) BamHI fragment from 12 kb (WT) to a 7 kb restriction fragment (TrkA^neo) after neo insertion. (C) Northern blot analysis of total RNA extracted from Dorsal Root Ganglia (DRG) neurons of E13.5 embryos either WT (+/+), heterozygous for the neo insertion (+/neo), homozygous for the neo insertion (neo/neo), or homozygous for the allele after neo removal with ß-actin cre (loxP/loxP), hybridized with a TrkA-kinase domain-specific probe (exon 14-17). Note that neo insertion completely eliminates TrkA-specific transcripts whereas TrkA-transcription is restored to WT levels after neo-excision by Cre recombination. (D) RT-PCR analysis of the same samples analyzed by northern blot. Specific primers for actin, neo, and TrkA exon 10 and 14 were used. Samples were treated with (+) and without (–) RT. Note the complete absence of the 609 bp TrkA-specific PCR product in TrkA^neo/neo mice. (E) Wholemount lacZ staining of a Rosa-26 E11.5 embryo with the T1-cre transgene. Note the specific staining in both central and peripheral nervous system. (F) lacZ staining of sections from spleen, thymus and bone marrow of adult Rosa-26 mice carrying the T1-Cre (top panels) or a ß-actin-Cre transgene with mosaic expression used as control (bottom panels) (Ma et al., 2003). Cre recombinase under the control of the T-1 promoter is only expressed in the nervous system (E) and not in organs of the immune system (F).

Return to article